What is the ICD‑10‑CM code for a routine screening mammogram in an asymptomatic patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 13, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

ICD-10-CM Code for Routine Screening Mammogram

Use ICD-10-CM code Z12.31 for routine screening mammography in asymptomatic average-risk women. 1

Code Specification and Application

  • Z12.31 is the designated code for encounters specifically for screening mammography in women without symptoms or known breast abnormalities 1
  • This code applies to all asymptomatic average-risk women undergoing routine screening, regardless of age (starting at 40 years) or breast density 1
  • The code remains Z12.31 for both annual and biennial screening intervals, as recommended by the American College of Radiology 1

Critical Coding Distinctions

Do not use Z12.31 for diagnostic mammography. 2 The following scenarios require different coding:

  • Symptomatic patients (breast pain, palpable mass, nipple discharge) require diagnostic codes based on the specific symptom 2
  • Follow-up of abnormal findings from prior imaging requires diagnostic coding, not screening codes 2
  • Surveillance after breast cancer treatment may use diagnostic mammography codes even in asymptomatic patients, depending on institutional protocol 2
  • Patients with prior breast-conserving therapy may be coded as diagnostic examinations even when asymptomatic, though some institutions return them to screening protocols 2

Age-Appropriate Screening Context

While Z12.31 is the code for all screening mammograms, the American College of Radiology provides these screening recommendations:

  • Ages 40-44: Opportunity to begin annual screening with Z12.31 1
  • Ages 45-54: Annual screening strongly recommended, coded as Z12.31 1
  • Ages 50-69: Biennial screening acceptable, though annual provides greater mortality reduction (40% vs 23%), both coded as Z12.31 1
  • Age 70+: Continue screening with Z12.31 if life expectancy exceeds 10 years 1

Common Coding Pitfalls to Avoid

  • Never use Z12.31 for women with breast symptoms, even if they are due for routine screening—the presence of symptoms mandates diagnostic coding 2
  • Do not confuse screening with diagnostic tomosynthesis—screening digital breast tomosynthesis also uses Z12.31, while diagnostic tomosynthesis requires different codes 2
  • Avoid using Z12.31 for high-risk surveillance in women with genetic mutations or strong family history who may require supplemental MRI—though mammography remains part of their screening, additional risk-based codes may apply 3

References

Guideline

Breast Cancer Screening Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Early Breast Cancer Screening for Women with a First‑Degree Family History

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.